Alamar Biosciences Inc
(NAS:ALMR)
$
36.02
+4 (+12.49%)
Market Cap: 2.50 Bil
Enterprise Value: 2.29 Bil
PE Ratio: 0
PB Ratio: 7.99
GF Score: 12/100 Alamar Biosciences Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 15, 2026 / 08:05PM GMT
Release Date Price:
$28.75
(+2.72%)
Unidentified Participant
Thank you very much for everyone for being here. It's my pleasure to have the Alamar team with us here today.
Yuling Luo, the Chief Executive Officer; and Justin McAnear, the Chief Financial Officer. So Yuling, Justin, welcome.
Justin McAnear
Alamar Biosciences Inc - Chief Financial Officer
Thank you.
Questions & Answers
Unidentified Participant
So maybe just to start off, for an investor that might be new to the Alamar story. What's the best way to understand where the company is at today and kind of how you fit into the broader ecosystem?
Yuling Luo
Alamar Biosciences Inc - Founder, Chairman of the Board, Chief Executive Officer
Alamar is establishing a gold standard in protein detection and analysis. We all know proteomics has huge potential to improve our understanding of health and disease, leading to better treatment and healthcare life. Despite all the great problems, this market remains to be largely untapped, mainly due to the
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot